PRLR and cancer: Deregulation of PRLR/PRL signaling is linked to other diseases and, although still debated, suggested to be implicated in the development and progression of prostate (Sackmann-Sala and Goffin, 2015) and breast (Clevenger and Rui, 2022) cancers.